HRTX - Heron Therapeuti

Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.

52W High

$2.68

52W Low

$1.04

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.23

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

44.71

EV/Revenue (<3 favorable)

2.25

P/S (TTM) (<3 favorable)

1.34

P/B (<3 favorable)

12.60

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.74%

Institutions (25–75% balanced)

87.88%

Shares Outstanding

153,292,000

Float

106,156,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

149,694,000

Gross Profit (TTM)

98,838,000

EPS (TTM)

-0.01

Profit Margin (>10% good)

-0.01%

Operating Margin (TTM) (higher better)

-0.04%

ROE (TTM) (>15% strong)

-24.09%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.03

Momentum

Bearish momentum

Value

-0.1015

-0.1036

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025